Health In Tech grants restricted stock awards to executive team for new programs

Health In Tech , Inc. (NASDAQ:HIT), a healthcare technology company with a market capitalization of $198.49 million and impressive revenue growth of nearly 30% in the last twelve months, announced that on Friday, the Compensation Committee of its Board of Directors approved grants of restricted stock awards to three executive officers in connection with the development of two new company programs.

According to a statement in a press release based on the company’s SEC filing, Chief Executive Officer Tim Johnson was granted 17,000 shares of restricted stock for each of Program 1 and Program 2, totaling 34,000 shares. Chief Financial Officer Linlin (Julia) Qian received 10,000 shares for Program 1 and 17,000 shares for Program 2, totaling 27,000 shares. Chief Technology Officer (Mo) Imran Yousuf was awarded 3,500 shares for each program, totaling 7,000 shares.

The vesting schedule for these awards is structured so that 50% of the shares for each executive will vest in equal monthly installments over a 12-month period beginning when the first of the two programs is successfully launched and fully operational in the marketplace. The remaining 50% will vest in equal monthly installments over a 12-month period starting from the launch and operational status of the second program.

The restricted stock awards were granted under the Health In Tech, Inc. Equity Incentive Plan and are subject to the terms and conditions set forth in the previously approved Restricted Stock Award Agreements.

Health In Tech, Inc. is listed on the Nasdaq Capital Market under the ticker HIT. The information in this article is based on a press release statement and the company’s current report filed with the Securities and Exchange Commission.

In other recent news, Health In Tech reported its second-quarter earnings for 2025, showing a mixed financial performance. The company posted earnings per share of $0.01, which was below the projected $0.02, resulting in a 50% negative surprise. However, Health In Tech’s revenue reached $9.3 million, marking an impressive 86% increase compared to the same period last year. Additionally, Health In Tech has regained compliance with Nasdaq’s minimum bid price requirement, receiving formal confirmation that it meets the exchange’s listing rule. In other developments, Health In Tech announced a new partnership with Verdegard Administrators, which will integrate its Enhanced Do It Yourself Benefit Systems (WA:BFT) platform with Verdegard’s third-party administration services. This collaboration aims to enhance services for self-funded health insurance plans. These recent developments reflect significant activities and strategic movements within the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.